Found 0 matching trials
Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma N/A Primary liver cancer is the second most common cause of cancer death in Chi...
Show More Location
Multiple Locations
Learn More & Join Trial
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer PHASE2 Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Show More Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Learn More & Join Trial
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC) PHASE2 This is a prospective, open-labelled study to evaluate the efficacy and saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC PHASE3 This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma PHASE4 Pain is the main complication after TACE(Transcatheter Arterial Chemoemboli...
Show More Location
The Second Affiliated Hospital, Chongqing Medical University
Learn More & Join Trial
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients NA This trial is designed to be the initial prospective pilot investigation of...
Show More Status
Active Not Recruiting
Location
Loyola University Medical Center
Learn More & Join Trial
A Study of PTX-9908 Injection for Non-resectable HCC with TACE PHASE1 This is a multicenter, Phase I/II study in patients with non-resectable hep...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) PHASE2 Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in...
Show More Location
The Fourth Affiliated Hospital of Haerbin Medical University
Learn More & Join Trial
Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy NA Although liver resection, liver transplantation, a-interferon, Transarteria...
Show More Location
9585 Humin Road,Xuhui district
Learn More & Join Trial
Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery PHASE2 RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial